Mesa Laboratories
MLAB
158 hedge funds and large institutions have $535M invested in Mesa Laboratories in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 51 increasing their positions, 56 reducing their positions, and 20 closing their positions.
30% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 20
3.24% more ownership
Funds ownership: 91.49% → 94.73% (+3.2%)
3% more funds holding
Funds holding: 154 → 158 (+4)
4% more capital invested
Capital invested by funds: $515M → $535M (+$19.8M)
9% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 56
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$27.2M |
| 2 |
RA
Royce & Associates
New York
|
+$10.1M |
| 3 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
+$6.24M |
| 4 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$4.7M |
| 5 |
BlackRock
New York
|
+$3.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Principal Financial Group
Des Moines,
Iowa
|
-$12.3M |
| 2 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
-$11M |
| 3 |
DDC
DF Dent & Co
Baltimore,
Maryland
|
-$5.73M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$3.61M |
| 5 |
KLC
Kent Lake Capital
Reno,
Nevada
|
-$2.96M |
MLAB Hedge Fund Activity: Q4 2023 in Review
158 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q4 2023, worth a combined $535M — up 3.8% from $515M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new MLAB positions and 20 closed out — a net gain of 6 holders — while 51 added to existing stakes and 56 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $27.2M. The largest seller was Principal Financial Group, cutting an estimated $12.3M.
- 158 institutional investors held Mesa Laboratories (MLAB) as of Q4 2023, up from 154 in Q3 2023.
- Funds reported $535M of Mesa Laboratories stock for Q4 2023, up 3.8% quarter-over-quarter.
- 26 funds opened new Mesa Laboratories positions in Q4 2023 and 20 closed out, a net change of +6 holders.
- The largest Mesa Laboratories buyer in Q4 2023 was Morgan Stanley, an estimated $27.2M added.
- The largest Mesa Laboratories seller in Q4 2023 was Principal Financial Group, an estimated $12.3M sold.
Based on aggregated 13F filings for Q4 2023.